Topotecan: after FDA and ASCO, what's next?
McNeil
C
C
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D012008:Recurrence; D019772:Topotecan; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D019772:Topotecan; D002166:Camptothecin